Clinical Trial Update: A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer [Phase 3]

View source ↗

Summary

Phase 3 trial update from AstraZeneca evaluating strategies to prevent rebleeding after initial endoscopic hemostasis of a bleeding peptic ulcer. The results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Hemorrhage
• Peptic Ulcer Bleeding

Snippet

Sponsor: AstraZeneca | Conditions: Gastrointestinal Hemorrhage | Phase 3 | Status: COMPLETED | Results posted: 2011-06-17